The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
The decision had been expected by April 1, but the agency now says it needs more information before moving forward.
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
Former Food and Drug Administration vaccine chief Dr. Peter Marks discussed his efforts to 'make nice' with Kennedy and ...
The top vaccine official with the Food and Drug Administration has resigned and criticized the nation's top health official ...
Tracy Beth Hoeg, a sports medicine physician and epidemiologist who opposed key U.S. health policies during the COVID-19 ...
“We are confident our well-tolerated vaccine represents an important alternative to mRNA Covid-19 vaccines for the US,” Novavax said. The FDA’s press office was put on administrative leave ...
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...